OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

Lightspeed is in discussions to lead the funding round, sources say.

By Marina Temkin · TechCrunch

Lightspeed is in discussions to lead the funding round, sources say.